As part of the non-exclusive long-term collaboration agreement, clinical systems company Ventana and biotechnology research company Genentech will develop the diagnostic tests for therapeutic candidates designated by Genentech.
In the study, investigators randomized 270 children to receive Daytrana, Johnson & Johnson’s extended-release ADHD drug Oros methylphenidate, or placebo. The 96 children in the Daytrana group reported
This decision was based on the recommendation of the trial’s independent data safety monitoring board (DSMB) after a planned interim analysis. The phase III trial is a double-blind
The companies plan to study the effects of psychiatric drugs in the brain at the molecular level with the help of biomarkers and Philips' medical imaging technology. As
San Diego-based Huya holds exclusive rights to the compound worldwide outside of China, while Chipscreen maintains rights in China. The phase I clinical trial is designed to assess
The company announced that Dr Hoyoung Huh has been promoted to COO and head of the PEGylation business unit. Recently, Nevan Elam was promoted to serve as the
VGX scientists created four synthetic consensus DNA vaccines to protect against a lethal Vietnamese H5N1strain of avian influenza in mice. One of the vaccines resulted in complete protection
The subpoena, issued from the New York state attorney general on May 10, sought documents relating to marketing activities, medical education and clinical studies, Amgen said. The company,
The license and supply agreement, which came into effect on March 16, 2007, will see the companies collaborate on the development and marketing of injectable Zileuton, Reuters said.
Wyeth said that the contraceptive is suitable for women who are interested in putting their menstrual cycle on hold, as the drug provides a steady low dose of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.